dansylsarcosine has been researched along with dicumarol in 1 studies
| Studies (dansylsarcosine) | Trials (dansylsarcosine) | Recent Studies (post-2010) (dansylsarcosine) | Studies (dicumarol) | Trials (dicumarol) | Recent Studies (post-2010) (dicumarol) |
|---|---|---|---|---|---|
| 40 | 1 | 5 | 2,260 | 33 | 110 |
| Protein | Taxonomy | dansylsarcosine (IC50) | dicumarol (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.0026 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.3 | |
| NAD | Homo sapiens (human) | 0.2585 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 4.426 | |
| Proprotein convertase subtilisin/kexin type 7 | Homo sapiens (human) | 1.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P | 1 |
1 other study(ies) available for dansylsarcosine and dicumarol
| Article | Year |
|---|---|
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence | 2010 |